跳至主要内容
临床试验/NCT00169624
NCT00169624终止3 期

The DIAMET Study: Peripheral and Coronary Endothelial Dysfunction in Type 2diabetic Patients- Evaluation of Reversibility Following 3 Months of Metformin Treatment

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年10月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
30
试验地点
1
主要终点
Flow dependent and independent Brachial artery vasoreactivity assessed using Doppler technology at 3 month vs baseline

研究概览

简要总结

Peripheral and coronary endothelial dysfunction in type 2 diabetic patients may be influenced by therapeutics. Using Radial flow monitoring and myocardial perfusion magnetic resonance imaging, we designed a controlled randomized double blind study to test the hypothesis that endothelial dysfunction will be reversed following 3 months of Metformin administration vs gliclazide. 30 patients will be included.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Double

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-70 years old, type 2 diabetes, non significant coronary atherosclerosis on inclusion coronary angiogram (ie no coronary stenosis > 70%), HbA1c<9%

排除标准

  • significant coronary stenosis (>70%), lack of informed consent, unstable hypertension, renal failure, contra-indication to metformin or gliclazide, pregnancy, atrial fibrillation, contraindication to MRI, or to adenosine, brachial artery calcifications

结局指标

主要结局

Flow dependent and independent Brachial artery vasoreactivity assessed using Doppler technology at 3 month vs baseline

次要结局

  • Myocardial perfusion improvement following improved vasoreactivity assessed using myocardial perfusion imaging at 3 month vs baseline

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验